SEELOS THERAPEUTICS, INC.
DelistedCIK 1017491fmd_1FJAF307DX033VPJQQZ7N73G3NManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2024, 58 periods
Latest annual · FY2023
Millions- Total revenues
- 2
- Operating income
- (40)
- Net income
- (38)
Latest quarter · Q2 FY2024
Millions- Total revenues
- 0
- Operating income
- (3)
- Net income
- 2
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- n/m
- Revenue, 5 yearsFY2018 to FY2023
- n/m
- Net income, 5 yearsFY2018 to FY2023
- n/m
SEELOS THERAPEUTICS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.2 million | 10-K 2024-03-06 · proof | ||
| Operating income | -$40.5 million | -$70.9 million | 10-K 2024-03-06 · proof | |
| Net income | -$37.9 million | -$73.5 million | 10-K 2024-03-06 · proof | |
| Cash from operating activities | -$23.9 million | -$61.6 million | 10-K 2024-03-06 · proof | |
| Total assets | $5.4 million | $22.7 million | -76.2% | 10-K 2024-03-06 · proof |
| Total liabilities | $38.9 million | $33.4 million | +16.7% | 10-K 2024-03-06 · proof |
| Cash and cash equivalents | $3 million | $15.5 million | -80.7% | 10-K 2024-03-06 · proof |
- What was SEELOS THERAPEUTICS, INC.'s revenue in fiscal 2023?
- SEELOS THERAPEUTICS, INC. reported revenue of $2.2 million for fiscal 2023 (the year ended Dec 31, 2023). Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
- What was SEELOS THERAPEUTICS, INC.'s operating income in fiscal 2023?
- SEELOS THERAPEUTICS, INC. reported operating income of -$40.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$70.9 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
- What was SEELOS THERAPEUTICS, INC.'s net income in fiscal 2023?
- SEELOS THERAPEUTICS, INC. reported net income of -$37.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$73.5 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
- What was SEELOS THERAPEUTICS, INC.'s cash from operating activities in fiscal 2023?
- SEELOS THERAPEUTICS, INC. reported cash from operating activities of -$23.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$61.6 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
- What are SEELOS THERAPEUTICS, INC.'s total assets?
- As of Dec 31, 2023, SEELOS THERAPEUTICS, INC. reported total assets of $5.4 million, against $22.7 million a year earlier (-76.2%). Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
- What are SEELOS THERAPEUTICS, INC.'s total liabilities?
- As of Dec 31, 2023, SEELOS THERAPEUTICS, INC. reported total liabilities of $38.9 million, against $33.4 million a year earlier (+16.7%). Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
- What are SEELOS THERAPEUTICS, INC.'s cash and cash equivalents?
- As of Dec 31, 2023, SEELOS THERAPEUTICS, INC. reported cash and cash equivalents of $3 million, against $15.5 million a year earlier (-80.7%). Source: the 10-K filed with the SEC on Mar 6, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1017491&period_type=annual&limit=5"Information only, not investment advice.